To teach an old dog new tricks: The limits of CHA2DS2-VASc in patients with atrial fibrillation and cancer

Xiaoxi Yao; Peter Noseworthy

doi:10.1177/2047487318766942

To teach an old dog new tricks: The limits of CHA₂DS₂-VASc in patients with atrial fibrillation and cancer

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	994-995
Number of pages	2
Journal	European Journal of Preventive Cardiology
Volume	25
Issue number	9
DOIs	https://doi.org/10.1177/2047487318766942
State	Published - Jun 1 2018

ASJC Scopus subject areas

Epidemiology
Cardiology and Cardiovascular Medicine

Access to Document

10.1177/2047487318766942

Cite this

@article{15cd37f0a6db438589dccf8cef88aa3f,

title = "To teach an old dog new tricks: The limits of CHA2DS2-VASc in patients with atrial fibrillation and cancer",

author = "Xiaoxi Yao and Peter Noseworthy",

year = "2018",

month = jun,

day = "1",

doi = "10.1177/2047487318766942",

language = "English (US)",

volume = "25",

pages = "994--995",

journal = "European Journal of Preventive Cardiology",

issn = "2047-4873",

publisher = "SAGE Publications Ltd",

number = "9",

}

TY - JOUR

T1 - To teach an old dog new tricks

T2 - The limits of CHA2DS2-VASc in patients with atrial fibrillation and cancer

AU - Yao, Xiaoxi

AU - Noseworthy, Peter

PY - 2018/6/1

Y1 - 2018/6/1

UR - http://www.scopus.com/inward/record.url?scp=85045050053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045050053&partnerID=8YFLogxK

U2 - 10.1177/2047487318766942

DO - 10.1177/2047487318766942

M3 - Comment/debate

C2 - 29592530

AN - SCOPUS:85045050053

VL - 25

SP - 994

EP - 995

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

SN - 2047-4873

IS - 9

ER -

To teach an old dog new tricks: The limits of CHA2DS2-VASc in patients with atrial fibrillation and cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

To teach an old dog new tricks: The limits of CHA₂DS₂-VASc in patients with atrial fibrillation and cancer